Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT00467194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: Rapamycin
DRUG: Bevacizumab

Sponsor

National Cancer Centre, Singapore